2,4-Dienoyl-CoA Reductase 2 (DECR2) Antibody

52€ (10 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
2,4-Dienoyl-CoA Reductase 2 (DECR2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx014696
tested applications
WB
Description
Rabbit polyclonal antibody against DECR2 protein. Immunogen region is C-terminal.
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | 2,4-Dienoyl-CoA Reductase 2 (DECR2) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
Clonality | Polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Purification | Purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen. |
Size 1 | 10 µg |
Size 2 | 100 µg |
Size 3 | 200 µg |
Size 4 | 300 µg |
Size 5 | 1 mg |
Form | Liquid |
Tested Applications | WB |
Buffer | PBS (without Mg<sup>2+</sup> and Ca<sup>2+</sup>), pH 7.4, 150 mM NaCl, 0.02% sodium azide, 50% glycerol. |
Availability | Shipped within 5-10 working days. |
Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
Dry Ice | No |
UniProt ID | Q9NUI1 |
Background | Antibody anti-DECR2 |
Status | RUO |
Note | Concentration: 1 mg/ml - |
Descripción
Related Products

DECR2 antibody
Auxiliary enzyme of beta-oxidation. Participates in the degradation of unsaturated fatty enoyl-CoA esters having double bonds in both even-and odd-numbered positions in peroxisome. Catalyzes the NADP-dependent reduction of 2,4-dienoyl-CoA to yield trans-3-enoyl-CoA. Has activity towards short and medium chain 2,4-dienoyl-CoAs, but also towards 2,4,7,10,13,16,19-docosaheptaenoyl-CoA, suggesting that it does not constitute a rate limiting step in the peroxisomal degradation of docosahexaenoic acid.
Ver Producto
Recombinant Human DECR2
Ver Producto
2,4-Dienoyl-CoA Reductase 2 (DECR2) Antibody
Rabbit polyclonal antibody against DECR2 protein. Immunogen region is C-terminal.
Ver Producto